NEOG vs ZTS
NEOG: Neogen provides essential diagnostic and safety solutions to protect the global food supply chain and enhance animal health and welfare. ZTS: Zoetis is the world's leading animal health company, providing a comprehensive portfolio of medicines, vaccines, and diagnostic technologies for both pets and livestock.
Side-by-side fundamentals
| Metric | NEOG | ZTS | Edge |
|---|---|---|---|
| Price as of 2026-07-31 close | $12.04 | $77.29 | |
| Market cap as of 2026-08-03 | $2.6B | $32.4B | |
| P/E as of 2026-08-03 | n/a | 12.80 | |
| PEG as of 2026-08-03 | n/a | 1.59 | |
| Net margin as of 2026-08-03 | -69.9% | +27.8% | ZTS higher |
| Gross margin as of 2026-08-03 | +45.2% | +71.8% | ZTS higher |
| Operating margin as of 2026-08-03 | -64.3% | +34.8% | ZTS higher |
| ROE as of 2026-08-03 | -29.0% | +62.4% | ZTS higher |
| ROA as of 2026-08-03 | -18.0% | +17.5% | ZTS higher |
| Debt / equity as of 2026-08-03 | 0.38 | 2.80 | NEOG lower |
| Revenue growth (YoY) as of 2026-08-03 | -3.9% | +2.4% | ZTS higher |
| Revenue CAGR (3y) SEC XBRL | +1.9% | +5.4% | ZTS higher |
| Dividend yield as of 2026-08-03 | n/a | +1.6% | |
| Dividend streak (yrs) SEC XBRL | n/a | 5 | |
| Beta as of 2026-08-03 | 0.38 | 0.56 | |
| 1-year return as of 2026-07-31 close | +158.9% | -47.0% | NEOG higher |
Fundamentals: market data, as of 2026-08-03. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-31.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.